MedTrace Logo

Moving Cupping for Plaque Psoriasis: a Randomized Controlled Trial

NCT03952676 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2019-05-16

No results posted yet for this study

Summary

The purpose of this study was to provide evidence support for the effectiveness and safety of moving cupping therapy for plaque psoriasis through clinical studies.

Conditions

Interventions

DEVICE

Moving cupping

1. We use a black opaque eye mask to shield the patient's eyes and choose different sizes of cup according to the location of the treatment (There are three sizes of cups) 2. (1) First apply Vaseline to the skin lesions area; (2) Then hold the 95% ethanol cotton ball with tweezers, and hold the cup with the facing down, after the cotton ball is ignited, immediately sway down in the cup and then exit, and quickly buckle the cup to the skin lesions area. (3) After using the cup to absorb the skin lesions area, hold the cup body in one hand and push and pull the cup along the certain route with a little strength, so that the skin purple color of the treatment area is suitable. (4) Apply even force when pushing the cup to prevent the cup from falling off due to air leakage. (5) Acting on the skin lesions area 30 times, change cup 5 times per push and pull, the interval is not more than 10 seconds.

DEVICE

Moving cupping placebo

Using of special perforated cups, the manipulation method is the same as the intervention group.

Sponsors & Collaborators

  • Shaanxi Traditional Chinese Medicine Hospital

    collaborator UNKNOWN

  • Heilongjiang University of Chinese Medicine

    collaborator OTHER

  • Shijiazhuang traditional Chinese medicine hospital

    collaborator UNKNOWN

  • The Affiliated Hospital of JiangXi University of TCM

    collaborator UNKNOWN

  • Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital

    collaborator UNKNOWN

  • Shanghai Yueyang Integrated Medicine Hospital

    lead OTHER

Principal Investigators

  • Jia Zhou · Shanghai Yueyang Integrated Medicine Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03952676 on ClinicalTrials.gov